Skip to main content
MedinCell S.A. logo

MedinCell S.A. — Investor Relations & Filings

Ticker · MEDCL ISIN · FR0004065605 LEI · 969500R79U6PXCL2FF46 PA Manufacturing
Open in API
Filings indexed 518 across all filing types
Latest filing 2026-03-06 Capital/Financing Update
Country FR France
Listing PA MEDCL

About MedinCell S.A.

https://www.medincell.com/en/

MedinCell S.A. is a pharmaceutical company at the commercial stage that specializes in the development of long-acting injectable (LAI) therapies. The company's core is its proprietary BEPO® technology platform, which enables the controlled and sustained release of active pharmaceutical ingredients over periods ranging from days to months after a single injection. This technology forms a fully biodegradable depot in situ, designed to improve treatment efficiency, enhance patient compliance, and increase the global accessibility of medicines. MedinCell develops a portfolio of LAI products across various therapeutic areas, including psychiatry, advancing its pipeline through both internal research and strategic partnerships with other pharmaceutical organizations.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 100% confidence The document is a press release from Medincell announcing the successful completion of a private placement of shares (capital raise) totaling 48 million euros. It details the number of shares issued, the price per share, the intended use of proceeds, and the impact on shareholding structure. This falls squarely under the definition of a 'Capital/Financing Update' (CAP), as it describes a specific fundraising activity and changes to the company's capital structure.
2026-03-06 French
Inside Information / Other news releases
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the launch of a private placement of shares by Medincell. It details the purpose of the capital raise, the accelerated book-building process, the target investors, and the expected settlement date. This falls under the category of capital and financing updates, as it describes a specific corporate action to raise capital through the issuance of new shares.
2026-03-05 English
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a private placement of shares (capital raise) by Medincell. It details the purpose of the funds, the process of the accelerated book-building, the financial intermediaries involved, and the legal restrictions regarding the offering. This falls squarely under the definition of a Capital/Financing Update (CAP).
2026-03-05 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release announcing Medincell's participation in upcoming investor conferences (Leerink and Jefferies). It does not contain financial results, proxy materials, or specific regulatory filings. Since it is a general corporate announcement regarding investor relations activities that does not fit into the other specific categories, it is classified as a Regulatory Filing (RNS).
2026-03-04 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release announcing the company's participation in upcoming investor conferences (Leerink and Jefferies). It does not contain financial results, audit reports, or specific regulatory filings, but rather serves as a general corporate announcement regarding investor relations activities. As it does not fit into more specific categories like 'Investor Presentation' (which would contain the actual slides/data) or 'Earnings Release', it is best classified as a general regulatory announcement.
2026-03-04 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release announcing Medincell's participation in an upcoming investor conference (TD Cowen 46th Annual Healthcare Conference). It provides details about the presentation date and contact information for investor relations. It does not contain financial statements, audit results, or regulatory filings, but rather serves as a corporate communication regarding investor outreach. As it does not fit into specific categories like earnings releases or reports, it is classified as a general regulatory announcement/press release.
2026-02-24 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.